{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:41:40Z","timestamp":1762389700999},"reference-count":3,"publisher":"Massachusetts Medical Society","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2020,4,2]]},"DOI":"10.1056\/nejmc2000116","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T21:01:30Z","timestamp":1585774890000},"page":"1378-1379","source":"Crossref","is-referenced-by-count":3,"title":["Asciminib in Relapsed Chronic Myeloid Leukemia"],"prefix":"10.1056","volume":"382","member":"150","reference":[{"key":"sa1r1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902328"},{"key":"sa1r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.07.006"},{"key":"sa1r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.08.004"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMc2000116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T21:01:38Z","timestamp":1585774898000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMc2000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":3,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,4,2]]}},"alternative-id":["10.1056\/NEJMc2000116"],"URL":"https:\/\/doi.org\/10.1056\/nejmc2000116","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]}}}